오흥범 교수
#진단검사의학과
|
학력
1997 .03 ~ 1999 .08서울대학교 의학 박사
1994 .03 ~ 1996 .02서울대학교 의학 석사
1982 .03 ~ 1988 .02서울대학교 의학 학사
1994 .03 ~ 1996 .02서울대학교 의학 석사
1982 .03 ~ 1988 .02서울대학교 의학 학사
경력
2009 .04 ~ 현재울산의대 서울아산병원 진단검사의학과 교수
2004 .04 ~ 2009 .03울산의대 서울아산병원 진단검사의학과 부교수
2001 .07 ~ 2002 .07미국 Harvard School of Public Health 연수
2000 .04 ~ 2004 .03울산의대 서울아산병원 진단검사의학과 조교수
1998 .03 ~ 2000 .03울산의대 서울아산병원 임상병리과 전임강사
1996 .07 ~ 1996 .08일본중앙적십자 혈액원
1996 .03 ~ 1998 .02대한 적십자사 혈액수혈연구원(감염연구과장 겸 면역연구과장)
1992 .05 ~ 1996 .02서울대학교병원 임상병리과 전공의
1989 .02 ~ 1992 .04육군 군의관
1988 .03 ~ 1989 .02전주 예수병원 인턴
2004 .04 ~ 2009 .03울산의대 서울아산병원 진단검사의학과 부교수
2001 .07 ~ 2002 .07미국 Harvard School of Public Health 연수
2000 .04 ~ 2004 .03울산의대 서울아산병원 진단검사의학과 조교수
1998 .03 ~ 2000 .03울산의대 서울아산병원 임상병리과 전임강사
1996 .07 ~ 1996 .08일본중앙적십자 혈액원
1996 .03 ~ 1998 .02대한 적십자사 혈액수혈연구원(감염연구과장 겸 면역연구과장)
1992 .05 ~ 1996 .02서울대학교병원 임상병리과 전공의
1989 .02 ~ 1992 .04육군 군의관
1988 .03 ~ 1989 .02전주 예수병원 인턴
논문
Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21 using maltose-binding protein.
Upconversion Nanoparticle-Based F?rster Resonance Energy Transfer for Detecting DNA Methylation.
Identification of a new HLA-A*24 allele, A*24:313
Identification of a new HLA-DRB1*04 allele, DRB1*04:10:03.
Identification of the novel allele, HLA-C*15:02:01:03, by full-length genomic sequencing.
Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.
A new HLA-A*02 allele, A*02:465.
Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing.
Identifying non-elliptical entity mentions in a coordinated NP with ellipses.
Analysis of hepartitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing
Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A
A novel HLA-A*31 allele, A*31:34, identified by sequence-based typing.
A processed HLA-A*24:02 pseudogene found in the peripheral blood of a father and his son.
A processed HLA-A*24;02 pseudogene found in the peripheral blood of a father and his son.
Artificial neural network weights of residues for the serological specificities of HLA.
HLA-C*03:93, a novel HLA-C*03 allele identified by sequence-based typing.
HLA-DQB1*05:06, a novel HLA-DQB1*05 allele identified by sequence-based typing.
HLA-DQB1*05:06, a novel HLA-DQB1*05 allele identified by sequence-based typing.
HLA-DRB1*13:99, a novel HLA-DRB1*13 allele identified by sequence-based typing.
HLA-DRB1*13:99, a novel HLA-DRB1*13 allele identified by sequencve-based typing.
Upconversion Nanoparticle-Based F?rster Resonance Energy Transfer for Detecting DNA Methylation.
Identification of a new HLA-A*24 allele, A*24:313
Identification of a new HLA-DRB1*04 allele, DRB1*04:10:03.
Identification of the novel allele, HLA-C*15:02:01:03, by full-length genomic sequencing.
Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.
A new HLA-A*02 allele, A*02:465.
Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing.
Identifying non-elliptical entity mentions in a coordinated NP with ellipses.
Analysis of hepartitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing
Multiplex polymerase chain reaction test for the diagnosis of acute viral hepatitis A
A novel HLA-A*31 allele, A*31:34, identified by sequence-based typing.
A processed HLA-A*24:02 pseudogene found in the peripheral blood of a father and his son.
A processed HLA-A*24;02 pseudogene found in the peripheral blood of a father and his son.
Artificial neural network weights of residues for the serological specificities of HLA.
HLA-C*03:93, a novel HLA-C*03 allele identified by sequence-based typing.
HLA-DQB1*05:06, a novel HLA-DQB1*05 allele identified by sequence-based typing.
HLA-DQB1*05:06, a novel HLA-DQB1*05 allele identified by sequence-based typing.
HLA-DRB1*13:99, a novel HLA-DRB1*13 allele identified by sequence-based typing.
HLA-DRB1*13:99, a novel HLA-DRB1*13 allele identified by sequencve-based typing.
저서
진단검사의학
의학 통계 전산 한꺼번에 맛보기
진단의약품의 임상평가 - 기초통계에서 실무지침까지
Clinical Microbiology for Infection Control
진단검사의학 완전개정 3판
의학 통계 전산 한꺼번에 맛보기
진단의약품의 임상평가 - 기초통계에서 실무지침까지
Clinical Microbiology for Infection Control
진단검사의학 완전개정 3판
보도자료
보도자료 내용이 없습니다.
포스팅
Single Center Study on Risk Factors for Allergic Reaction During Therapeutic Plasma Exchang
Prevalence of donor specific anti-HLA antibody in T cell-depleted haploidentical stem cell transplantation
Allele Frequencies of Human Leukocyte Antigen-A, -B, and -DR Loci in zero-HLA mismatched renal
allograft recipients
Prevalence of donor specific anti-HLA antibody in T cell-depleted haploidentical stem cell transplantation
Allele Frequencies of Human Leukocyte Antigen-A, -B, and -DR Loci in zero-HLA mismatched renal
allograft recipients
영상자료
영상자료 내용이 없습니다.
발표자료
정량적 면역반응검사에 사용되는 비선형 calibration모델
Association of HLA Alleles, Haplotypes, and Shared Epitopes with Autoimmune Hepatitis of Koreans
determination of HLA class II allele and haplotype frequencies in Koreans and phylogenetic analysis
Association of specific amino acid sequence of HLA-DR with autoimmune hepatitis in Koreans
Association of HLA Alleles, Haplotypes, and Shared Epitopes with Autoimmune Hepatitis of Koreans
determination of HLA class II allele and haplotype frequencies in Koreans and phylogenetic analysis
Association of specific amino acid sequence of HLA-DR with autoimmune hepatitis in Koreans